Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis

BACKGROUND: Antifibrotic therapy can slow disease progression (DP) in patients with idiopathic pulmonary fibrosis (IPF). However, the prognostic biomarkers for DP in patients with IPF receiving antifibrotic therapy have not been identified. Therefore, we aimed to evaluate the prognostic efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Myeong Geun, Choi, Sun Mi, Lee, Jae Ha, Kim, Joong-Yub, Song, Jin Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733030/
https://www.ncbi.nlm.nih.gov/pubmed/36494685
http://dx.doi.org/10.1186/s12931-022-02273-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733030/
https://www.ncbi.nlm.nih.gov/pubmed/36494685
http://dx.doi.org/10.1186/s12931-022-02273-6

Ejemplares similares